美利医疗系统 MMSI

Ms. Martha G. Aronson serves as Director, President and Chief Executive Officer at the company. Her Career Highlights includes Merit's President and CEO since October 2025, Member of the Board of Directors (Chair and Lead Independent Director) of ConMed Corporation, 2016 to 2025, Member of the Board of Directors of Bright Uro, 2023 to 2025, Member of the Board of Directors of Cardiovascular Systems, Inc. (acquired by Abbott Laboratories), 2017 to 2023, Chair of the Board of Directors and Interim Chief Executive Officer of Beta Bionics, 2020 to 2022, President, Global Healthcare of Ecolab Inc., 2012 to 2016, President, North American of Hill-Rom Holdings, Inc. (acquired by Baxter International), 2010 to 2012, Various general management and functional leadership roles in the U.S. and Europe at Medtronic, 1991 to 2009, Member of the Board of Trustees, Wellesley College, 2018 to present and Member of the Board of Directors of several private companies and non-profit organizations. Her Education includes B.S. (Economics) Wellesley College; M.B.A., Harvard Business School.

Mr. Raul Parra, Jr, Previous positions at Merit include, Vice President of Accounting, Corporate Controller and Director of Financial Reporting, Before joining Merit, held various audit and managerial positions at Deloitte & Touche, LLP and Director and Audit Committee Chair, American Express National Bank, 2022 to present. His education includes B.S. (business administration with accounting emphasis), Sonoma State; Certified Public Accountant (Inactive).

Brian G. Lloyd, Practiced as an attorney, specializing in corporate governance, securities regulation and mergers & acquisitions, with the law firm of Parr Brown Gee & Loveless, PC in Salt Lake City, Utah for more than 20 years. He Also practiced law in those areas of specialization as a partner with the law firm of Stoel Rives, LLP for four years, His education includes B.S. (finance), Brigham Young University; J.D., Columbia Law School

Mr. Neil Peterson, More than 30 years of service to Merit and its shareholders and Previous positions at Merit include Vice President Operations (March 2017 to April 2022), His education includes B.S. (electronic engineering), Weber State University. On August 14, 2026, Merit Medical Systems, Inc. (Merit) reorganized portions of its global operations function. As a result of such reorganization, the position of Chief Operating Officer was eliminated, and Neil W. Peterson's title was changed to Senior Advisor. On August 18, 2026, Mr. Peterson provided Merit with written notice of his resignation for good reason as an employee of the Company effective March 5, 2027.

Mr. Michel James Voigt, is Former Chief Human Resources Officer of Mavenir Systems, Inc. from 2017-2020 and Over 20 years of experience in human resources management in various positions at Nestle, Lexicon Pharmaceuticals Incorporated, and Verizon. His education includes B.S. (business administration and management), Oklahoma State University

F. Ann Millner, Ed.D., Regents Professor and Professor of Health Administrative Services at Weber State University, 2013 to present ; Member of the Utah State Senate (member of multiple committees and subcommittees), 2015 to present ; Executive Committee of National Conference of State Legislatures, 2023 to present ; Member of Board of Trustees of Intermountain Health (integrated multi-state health system), 2005 to present ; President of Weber State University, 2002 to 2012 (first female president of a Utah state university) ; Vice President of University Relations at Weber State University, 1993 to 2002 ; Associate Dean of Continuing Education and Assistant Vice President of Community Partnerships at Weber State University, 1985 to 1993. Education: B.S. (education), University of Tennessee; M.S. (allied health education and management), Southwest Texas State University; Ed.D (education administration), Brigham Young University; Completed medical technology program, Vanderbilt University. F. Ann Millner, Lead Independent Director, has been appointed to the board as Chairman of the Board with effect from 05th Jan 2026.

Ms. Lynne N. Ward, Executive Director of my529 (formerly known as the Utah Educational Savings Plan), offering municipal fund securities, 2004 to 2019. Underlying investments were with Vanguard, Dimensional, PIMCO, Sallie Mae Bank and U.S. Bank. Member of the University of Utah's Investment Advisory Committee, 2018 to 2025. Member of the National Association of Corporate Directors (Utah Chapter), 2017 to 2023. Walker Institute at Weber State University board of directors, 2012 to 2020, Member, AICPA (American Institute of Certified Public Accountants) 1981 to present, Member, UACPA (Utah Association of Certified Public Accountants) 1985 to present and Cox for Governor, 2020. Her Education includes B.S. University of Utah (Accounting).

Mr. Carpenter, Member of the Board of Directors of Orchid Orthopedics Solutions (a privately-owned orthopedic medical device outsourcing company), 2019 to present ; Member of the Board of Directors of The Boler Company, (a privately-owned auto part manufacturing company), 2019 to present ; Member of the Board of Directors (Lead Independent Director) of Novanta Inc., a manufacturer of precision photonic and motion control components and subsystems, 2018 to 2024 ; Group President, Global Quality and Business Operations, Stryker Corporation, 2016 to 2019 ; Group President, Global Quality and Operations, Stryker Corporation, 2011 to 2016 ; President, Instruments and Medical Division, Stryker Corporation, 2006 to 2008 ; Captain in the U.S. Army and helicopter pilot having served in leadership roles for the 101st Airborne Division. Other Public Boards: Novanta Inc. Education: B.S., United States Military Academy at West Point.

Mr. Thomas J. Gunderson, Member of the Board of Directors of TransMedics Group, Inc., a medical technology company focused on developing organ transplant therapy for end-stage organ failure patients, 2019 to present, Chair of the Minneapolis Heart Institute Foundation, (Director from 2011 to present, Chair from 2015 to 2020 and 2024 to present), Executive in Residence at the University of Minnesota's Medical Industry Leadership Institute, 2016 to present, Member of American Heart Association Science and Technology Accelerator Committee, 2015 to 2017, Managing Director and senior research analyst at Piper Jaffray (focus on medical technology companies), 1992 to 2016, Project Director at American Medical Systems (private medical device company acquired by Pfizer in 1983), 1979 to 1992 and Recognized by several industry publications, including the Wall Street Journal, Institutional Investor, First Call, Thomson Reuters, and Medical Device and Diagnostic Industry (e.g., in 1996 and 2000, he was named an All-Star Analyst for medical stocks by the Wall Street Journal and in 2014, Thomson-Reuters named him Top Stock Picker in the medical technology sector) His education includes B.A. (biology focus), Carleton College; M.S. (cell biology), University of Minnesota; M.B.A., University of St. Thomas.

Ms. Laura S. Kaiser, Education: B.S. (health sciences management), University of Missouri; M.B.A., Saint Louis University; Masters of Health Administration, Saint Louis University. Career Highlights: President and Chief Executive Officer of SSM Health, an integrated multi-state health system with more than 40,000 employees and 35 hospitals, medical group, health plan and pharmacy benefit management company, 2017 to present ; Former Chairperson of Catholic Health Association of the United States, representing more than 600 hospitals and 1,600 long-term care and other health facilities in all 50 states, 2018 to 2024 ; Board Director, American Hospital Association, 2024 to present ; Served on the Board of Directors for Nuance Communications, a multinational computer technology company acquired by Microsoft Corp., 2017-2022 ; Previously served as the Chief Operating Officer of Intermountain Health, an integrated multi-state health system with 24 hospitals, 2012 to 2017 ; Named one of the 100 Most Influential People in Healthcare by Modern Healthcare for the past seven years .

Ms. Silvia M. Perez, President of Commercial Branding and Transportation, a $2.6 billion revenue division of 3M Company, a multinational NYSE-listed company operating in the fields of industry, consumer goods and worker safety, 2023 to present, President of Commercial Solutions Division of 3M Company, an approximate $1.8 billion revenue division, 2020 to 2023, Interim President of Acelity acquisition, overseeing the integration of Acelity into 3M Company, which was the largest acquisition in the history of 3M Company, 2019 to 2020, Various leadership roles within the healthcare business of 3M Company, both domestic and international, 1994 to 2019 and Obtained Six Sigma Black Belt and Master Black Belt Certifications. Her Education includes Pharmaceutical Chemist, University of the Republic (Uruguay); Industrial Pharmacist, Federal University of Parana (Brazil).

Mr. Michael R. Mcdonnell's Career Highlights includes, Director of Baxter International, February 2026 to present, Advisor to Goldman Sachs Asset Management and Leader of Finance Center of Excellence for Private Equity Buyout Funds, 2025 to present, Chief Financial Officer of Biogen Inc, a multinational Nasdaq-listed company engaged in discovering, developing, and delivering therapies for people living with serious and complex diseases, 2020 to 2025, Executive Vice President and Chief Financial Officer of IQVIA Holdings Inc., a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry, 2015 to 2020, Executive Vice President and Chief Financial Officer of Intelsat, a global provider of satellite services, 2008-2015, Chief Operating Officer (2006-2008) and Chief Financial Officer (2004-2008) of MCG Capital Corporation, a publicly-held commercial finance company, 2004 to 2008, Chief Financial Officer of EchoStar Communications Corporation (dba Dish Network), a satellite television provider, 2000 to 2004, Partner of PricewaterhouseCoopers, LLP, 1996 to 2000, other positions, PricewaterhouseCoopers, LLP, 1986-1996, Director of Catalyst Health Solutions, Inc., a publicly-held pharmacy benefits management company, 2005 to 2012, Finance Committee Member, Atlantic Health System, owner and operator of over 400 care sites including six hospitals in New Jersey, 2021 to present and He is Certified public accountant. His Education: B.S. (accounting), Georgetown University.

Rear Admiral (Ret.) Stephen C. Evans, Served in the United States Navy, most recently as Special Advisor to the Commander, Naval Operations, before retiring in 2020. During more than 20 years of service in the United States Navy, Admiral Evans held a variety of leadership positions, including Senior Advisor, Deputy U.S. Military, NATO Military Committee; Commander, George H. W. Bush Carrier Strike Group; and Commander, Naval Service Training Command, Served on diplomatic missions in over 64 countries, delivering results in international diplomacy and military relations to establish enduring, productive global partnerships, Commanded U.S. naval forces in six operational theaters, Served in a senior strategic advisory role to the 75th Secretary of the Navy and Represented the U.S. in deliberations and actions of NATO, providing counsel to Heads of State in Europe and around the world. His education includes M.A., U.S. Naval War College (National Security Affairs), B.A., The Citadel.

Effective August 31, 2026, Merit appointed Sheri Lewis as Merit's Executive Vice President of Global Operations. Prior to her appointment with Merit, Ms. Lewis was employed from April 2024 as Chief Supply Chain and Operations Officer of Skin Health Systems. Ms. Lewis was employed as Executive Vice President, Global Supply Chain Operations, of Avantor Sciences from January 2021 until March 2024 and previously served in multiple operations, supply chain and distribution positions with Medtronic and Honeywell Inc. Ms. Lewis holds a Bachelor of Arts degree in Organizational Management from Concordia University, currently serves as a member of the Supply Chain Advisory Board at the University of Wisconsin and previously served as a member of the Supply Chain Advisory Board at the University of Minnesota.

Mr. Scott R. Ward President and Managing Director of Raymond Holdings, LLC, a firm focused on the life sciences with activities in venture capital, corporate strategy, and transactional advisory services, 2010 to present, President and Chief Executive Officer of Cardiovascular Systems, Inc. (acquired by Abbott Laboratories), 2016 to 2023; Chair of the Board of Cardiovascular Systems, Inc. from 2014 to 2023, Managing Director at SightLine Partners, an investment firm focused on private medical technology, digital health and life sciences companies, 2012 to 2016, Various senior leadership roles at Medtronic, including Senior Vice President and President of Cardiovascular, Vascular, Neurological and Diabetes Businesses, leader of Medtronic's Neurological ventures and various other functional roles, 1981 to 2010 and Member of the Board of Directors of several private companies and non-profit organizations. His education includes B.S. (Biology) University of Minnesota. Mr. Ward appoint director.

Mr. C. Adam Smith serves as Chief Commercial Officer of company, He has Over 20 years of experience in the medical device industry, technology startups, and the recreation sector. Previous positions at Merit include Executive Vice President, U.S. and EMEA (October 2024 to May 2025); (ii) President, EMEA (October 2021 to October 2024); and (iii) Senior Director, International (January 2019 to October 2021).